MD · State regulatory reference
Maryland.
Moderate
Maryland regulates telehealth practice of medicine through the Board of Physicians under COMAR 10.32.05, which requires a patient evaluation adequate to establish diagnoses before prescribing and prohibits prescribing based solely on an online questionnaire; a synchronous audio-video initial visit is a permitted evaluation method. Sterile compounding under the Board of Pharmacy's COMAR 10.34.19 expressly adopts USP <795> (non-sterile) and <797> (sterile). No distinctive restrictive or permissive signal specific to peptides or GLP-1 telehealth was found.
Last reviewed · 2026-05-25 · verified entry
Agencies
TPC notes
Telehealth
COMAR 10.32.05 permits establishing care via synchronous audio-video but requires a patient evaluation 'adequate to establish diagnoses and identify underlying conditions' before prescribing and bars prescribing based solely on an online questionnaire; opioid prescribing via telehealth is limited to patients in a health care facility.
Compounding
The Board of Pharmacy's compounding rules (COMAR 10.34.19) incorporate USP <795> and <797>, including ISO clean-room classifications, contamination/adverse-event reporting, and facility permitting; injectable peptide/GLP-1 compounding falls under these 503A sterile requirements.
Sources